Siemens 2006 Annual Report Download - page 56

Business Areas
Medical
56
Medical Solutions (Med)
By 2050, there will be more people over
60 than under 14. As the world’s popula-
tion grows and ages, the demand for
healthcare products, services and solu-
tions will increase. To ensure high-quality,
patient-centric and affordable medical
services in the future, it will be necessary
to optimize efficiencies all along the
healthcare continuum.
We’re convinced that breakthroughs in
the fields of early diagnosis and interven-
tion as well as high-performance IT solu-
tions for optimizing clinical and adminis-
trative workflows are the keys to success.
With the help of these innovative tech-
nologies, we’re equipping healthcare
delivery systems around the world to
meet the needs of the future by enhanc-
ing the quality of care while cutting costs.
Important innovative trends include
knowledge-based decision support and
an intense focus on all the factors con-
tributing to disease. Due to its many
applications in individualized therapy and
early disease detection, molecular diag-
nostics – the use of in-vivo and in-vitro
technologies in gene and protein analysis
– is steadily gaining in importance.
To serve these new growth areas and
optimize financial outcomes, we’ve
extended our portfolio and broadened our
expertise through acquisitions over the
last few years. Expanding into the field
of molecular diagnostics, we recently
acquired CTI Molecular Imaging. The
acquisition of Diagnostic Products Corpo-
ration and Bayer Diagnostics will widen
our focus to include in-vitro as well as in-
vivo procedures. Together, these acquisi-
tions will make us the world’s first full-
service diagnostics company, combining
imaging diagnostics, laboratory diagnos-
tics and clinical IT under one roof.
We now provide comprehensive solu-
tions – networked on our Soarian and
syngo platforms – across the entire
healthcare continuum, from prevention
and diagnosis to treatment and follow-up
care.
www.siemens.com/medical
Med will soon be the first
healthcare supplier to pro-
vide a full range of diagnos-
tics procedures featuring all
key in-vitro and in-vivo tech-
nologies. Networked on the
Soarian and syngo IT plat-
forms, our comprehensive
offerings have enabled us to
capture a strong position in
our market.
Highlights in fiscal 2006
•Acquiring Bayer Diagnostics and Diagnostic
Products Corporation will make us the
world’s first integrated diagnostics company.
• We signed agreements to keep London’s St.
Bartholomew’s Hospital and the Royal Lon-
don Hospital equipped with state-of-the-art
healthcare systems for 35 years, starting at
the end of 2009.
•Rhön-Klinikum AG commissioned us to sup-
ply a particle therapy system in Marburg,
Germany. Treatment will be available to
patients by 2010. The system will be operat-
ed in close collaboration with Universitäts-
klinikum Gießen und Marburg GmbH.
As demographics change, how can
Siemens help prepare healthcare
systems for the challenges of
tomorrow?
IT-based innovation and process
optimization are the main levers
for improving the quality of care and
cutting costs. Our goal is to achieve
high-efficiency, patient-oriented
healthcare based on proven out-
comes.